Two clinical studies presented at the 2026 Science of Skin Summit demonstrated that targeted skincare regimens and DiamondGlow® dermabrasion treatments significantly improved skin quality in individuals using medical weight loss medications like GLP-1 receptor agonists. Participants showed visible improvements in dryness, skin tone, texture, and youthful appearance, with some reporting their skin looked up to 10 years younger after treatment. These findings highlight potential aesthetic benefits for patients undergoing medical weight loss, with further research needed to confirm results in larger groups.
The new clinical data on skin quality improvements related to medical weight loss medications provides context for health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Sep 17, 2026 18:11 WIB: Of 91 priced health-sector US stocks tradable on Pluang, 63 rose and 25 fell today. Notable movers include ASND at USD 239.50 with a 1-day change of -3.31% and a typical hold time of 55 days, SANA at USD 3.00 up 2.74% with a 22-day hold time, and TWST at USD 146.86 up 2.65% with a 28-day hold time.
BDR Pharmaceuticals has filed a lawsuit against the FDA, disputing the agency's refusal to accept an abbreviated new drug application referencing Phathom Pharmaceuticals' VOQUEZNA. BDR claims the FDA wrongly extended Phathom's exclusivity period unde...
Ipsos achieved 2.0% organic revenue growth in Q3 2026, up from 0.8% in H1, driven by strong performances in EMEA, China, and citizen-related activities. The company updated its 2026 organic growth target to 1.2%-1.5%, reflecting improved momentum and...
Ipsos posted €636.2 million revenue in Q3 2026 with 2.0% organic growth, up from 0.8% in H1, led by strong performances in EMEA, China, and its Citizens business. The company updated its full-year organic growth outlook to 1.2%-1.5%, citing ongoing g...
Signify reported third-quarter 2026 results with sales of EUR 1,367 million, a slight decline in comparable sales by 3.4%, but improved adjusted EBITA of EUR 145 million and a margin increase to 10.6%. Net income rose to EUR 88 million and free cash ...
Pump.fun has introduced new take-profit and stop-loss order tools specifically for trades on Ethereum Virtual Machine (EVM) platforms. These tools allow traders to better manage their positions by automatically securing profits or limiting losses. Th...
